Nurix Therapeutics Ownership | Who Owns Nurix Therapeutics?
Nurix Therapeutics Ownership Summary
Nurix Therapeutics is owned by 105.38% institutional investors, 1.09% insiders. Blackrock is the largest institutional shareholder, holding 12.42% of NRIX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Nurix Therapeutics shares.
NRIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nurix Therapeutics | 105.38% | 1.09% | -6.47% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.82M | 12.42% | $142.33M |
| Blackrock funding, inc. /de | 8.93M | 8.11% | $138.35M |
| Redmile group | 7.73M | 7.03% | $119.86M |
| Vanguard group | 5.95M | 6.26% | $112.86M |
| Vestal point capital, lp | 6.50M | 5.91% | $100.75M |
| Deep track capital, lp | 6.35M | 5.76% | $98.35M |
| Fmr | 5.54M | 5.03% | $85.89M |
| State street | 5.14M | 4.67% | $79.69M |
| Morgan stanley | 4.93M | 4.48% | $76.45M |
| Baker bros. advisors lp | 4.66M | 4.23% | $72.21M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 7.73M | 7.94% | $119.86M |
| General atlantic | 4.10M | 2.96% | $63.58M |
| Vestal point capital, lp | 6.50M | 2.82% | $100.75M |
| Commodore capital lp | 2.27M | 2.04% | $35.26M |
| Deep track capital, lp | 6.35M | 1.61% | $98.35M |
| Foresite capital management v | 265.00K | 1.52% | $4.11M |
| Verdad advisers, lp | 83.42K | 1.46% | $1.29M |
| Kynam capital management, lp | 1.19M | 1.14% | $18.52M |
| Perceptive advisors | 3.71M | 1.13% | $57.52M |
| Highvista strategies | 226.55K | 0.97% | $3.51M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 6.82M | 0.00% | 2.24M |
| Vestal point capital, lp | 6.50M | 2.82% | 1.81M |
| State street | 5.14M | 0.00% | 1.58M |
| Vanguard group | 5.95M | 0.00% | 1.46M |
| Fmr | 5.54M | 0.00% | 1.31M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 449.11K | 0.01% | -2.76M |
| Ra capital management | - | - | -1.33M |
| Bain capital life sciences investors | - | - | -1.13M |
| General atlantic | 4.10M | 2.96% | -795.29K |
| Kynam capital management, lp | 1.19M | 1.14% | -775.60K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Capital world investors | 893.33K | 0.00% | 893.33K | $13.85M |
| Vanguard fiduciary trust | 632.23K | 0.00% | 632.23K | $9.80M |
| Fisher asset management | 384.83K | 0.00% | 384.83K | $5.96M |
| Raymond james financial | 353.73K | 0.00% | 353.73K | $5.20M |
| D. e. shaw | 344.20K | 0.00% | 344.20K | $5.34M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -4.00 |
| Ifp advisors | -6.00 |
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Federated hermes | -15.00 |
| Amundi | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 192 | 3.23% | 115,991,739 | 2.27% | 105 | 0.62% | 107 | -19.55% | 42 | 50.00% |
| Dec 31, 2025 | 39 | -77.59% | 15,163,987 | -82.11% | 15 | 0.16% | 26 | -68.67% | 7 | -88.14% |
| Sep 30, 2025 | 46 | -72.12% | 9,091,319 | -89.71% | 10 | 0.10% | 18 | -80.43% | 17 | -59.52% |
| Jun 30, 2025 | 164 | -4.09% | 88,304,128 | 5.07% | 105 | 1.04% | 91 | -3.19% | 42 | -17.65% |
| Mar 31, 2025 | 171 | -3.93% | 84,588,676 | 4.29% | 101 | 0.69% | 93 | -11.43% | 51 | 10.87% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.25M | 3.14% | 15.55K |
| State Street® SPDR® S&P® Biotech ETF | 3.13M | 3.03% | -30.98K |
| Vanguard US Total Market Shares ETF | 2.13M | 2.79% | 196.50K |
| iShares Russell 2000 ETF | 2.38M | 2.30% | 20.07K |
| Fidelity Select Health Care | 1.69M | 2.21% | 90.00K |
| Xtrackers MSCI World Swap ETF 1C | 2.14M | 2.08% | -13.47K |
| US Small-Cap Growth II Equity Comp | 1.35M | 1.76% | 14.21K |
| Pictet-Biotech P USD | 1.79M | 1.73% | 7.04K |
| ARK Genomic Revolution ETF | 1.72M | 1.67% | 72.94K |
| ARK Genomic Revolution | 1.63M | 1.57% | 96.44K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 02, 2026 | Ring Christine | Chief Legal Officer | Sell | $135.25K |
| May 05, 2026 | van Houte Hans | Chief Financial Officer | Sell | $10.00K |
| May 05, 2026 | van Houte Hans | Chief Financial Officer | Sell | $223.32K |
| May 04, 2026 | Ring Christine | Chief Legal Officer | Sell | $138.21K |
| May 01, 2026 | Ring Christine | Chief Legal Officer | Sell | $90.41K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 9 |
| 2026 Q1 | - | 9 |
| 2025 Q4 | - | 7 |
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 4 |
NRIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools